Mice flown aboard the International Space Station and exposed to Mars-like gravity for roughly a month showed only partial protection against muscle deterioration, according to a peer-reviewed study that raises pointed questions about whether the Red Planet’s pull is strong enough to keep future astronauts healthy. The findings land as space agencies plan crewed Mars missions that would require humans to live and work in gravity roughly one-third of Earth’s for months at a time. If Mars gravity alone cannot prevent muscle wasting, crews may need additional countermeasures well beyond what current mission architectures assume.
What the ISS Mouse Experiment Found
The experiment was part of the MHU-8/JAXA MARS partial-gravity mouse mission, which launched on March 14, 2023, and returned on April 16, 2023. Researchers housed mice inside a centrifuge habitat on the station, exposing separate groups to microgravity, 0.33 g (approximating Mars), 0.67 g, and a full 1 g control for approximately 27 to 28 days. The results split sharply along the gravity gradient. According to findings published in Science Advances, mice at 0.67 g preserved forelimb grip strength and were protected from soleus muscle atrophy and changes in myofiber-type composition. Mice at 0.33 g, by contrast, showed only partial protection against those same markers of decline.
That distinction matters because the soleus, a slow-twitch calf muscle critical for posture and locomotion, is one of the first muscles to degrade in reduced gravity. A shift from slow-twitch to fast-twitch fibers signals the muscle is losing its endurance capacity, the very quality astronauts would need for sustained surface operations on Mars. The 0.33 g group retained some muscle mass but still experienced fiber-type changes, suggesting that Mars gravity may slow atrophy without truly preventing the functional losses that compromise movement and strength.
Gait and Neuromotor Deficits Follow the Same Pattern
A companion study from the same mission examined a different set of outcomes: how well mice walked and coordinated movement after living at various gravity levels. That research, published in Life Sciences in Space Research, reported that neuromotor and gait performance also degraded in a gravity-dose-dependent manner. Mice at 0.67 g fared significantly better than those at 0.33 g, and both outperformed the microgravity group. The convergence of muscle histology data and gait performance data from the same mission strengthens the case that Mars-level gravity sits below the threshold needed to maintain normal physical function, at least in mice over a roughly four-week period.
No one has yet tested these gravity levels on humans in orbit. All evidence for partial-gravity effects on mammalian muscle comes from rodent analogs, and the longest exposure in these experiments lasted less than a month. A crewed Mars surface stay could last 500 days or more, making the gap between available data and mission reality a serious planning concern.
Earlier Studies Hinted at This Problem
The new results build on earlier ISS research that used the same JAXA centrifuge system at roughly one-sixth g, simulating lunar gravity. That study, reported in Communications Biology, found that lunar-level gravity prevented skeletal muscle atrophy in mice but did not stop the slow-to-fast myofiber-type transition. The implication was clear even then: partial gravity can preserve muscle size while still allowing the internal composition of muscle fibers to shift in ways that reduce endurance and functional capacity.
A NASA technical report presented at the 50th International Conference on Environmental Systems in July 2021 went further. That paper, designated ICES-2021-142 and available through a NASA repository, argued that the partial gravity of both the Moon and Mars appears insufficient to maintain human health, citing risks that extend beyond muscle to include bone loss, cardiovascular deconditioning, and spinal issues. The report called for serious consideration of artificial gravity as a countermeasure, a position the latest mouse data now supports with direct experimental evidence.
The Scale of Muscle Loss in Spaceflight
The baseline risk is well established. Studies of crews over the last fifty years of human spaceflight reveal that astronauts can lose up to 20 percent of their muscle mass during missions, according to Harvard Medical School. That figure comes from microgravity exposure on the ISS and earlier stations, where crews float rather than stand or walk. The hope behind Mars missions has always been that the planet’s 0.38 g would provide enough loading to slow or stop that decline. The mouse data suggests the hope was optimistic.
NASA has long invested in countermeasures to fight muscle and bone loss. Current approaches on the ISS include exercise hardware, dietary interventions, and tissue chip research designed to test pharmaceutical options in microgravity, as described in a NASA overview. But exercise equipment is heavy, takes up crew time, and may not fully replicate the loading patterns of Earth gravity. If Mars gravity provides only partial protection, the exercise burden on surface crews could be substantial, eating into time available for science and exploration.
Countermeasures Beyond Exercise
One line of research has explored whether dietary supplements could fill the gap. Harvard Medical School researchers found that supplementing diets with resveratrol, a compound found in grape skins and red wine, could help maintain musculoskeletal health in simulated partial gravity. That finding, while promising, came from ground-based rat studies rather than orbital experiments, and no human trials in actual reduced gravity have followed.
Other proposed countermeasures include pharmacological agents that target muscle growth pathways and neuromuscular stimulation devices that could provide mechanical loading without full-body workouts. These approaches remain largely experimental, and none has yet been validated in the kind of long-duration, partial-gravity setting that a Mars mission would entail. For now, exercise and habitat design are the main tools planners can count on.
Artificial Gravity Moves From Concept to Requirement
The notion of spinning spacecraft or habitats to generate artificial gravity has been a staple of science fiction for decades, but engineering realities and cost have kept it on the margins of mission planning. The new mouse data, combined with earlier lunar-gravity findings and NASA’s own risk assessments, are pushing it closer to the center. If 0.33 g is not enough to maintain muscle function, and 0.67 g performs markedly better, designers may need to consider rotating modules or short-radius centrifuges that can deliver higher effective gravity for at least part of each day.
NASA’s technical community has been exploring these ideas through internal studies and conference papers, many of which are cataloged in the agency’s scientific and technical information portal. Concepts range from small, bicycle-like centrifuges that astronauts could use for daily “gravity workouts” to larger rotating habitats that would provide continuous loading. Each option carries trade-offs in mass, complexity, and crew comfort, but the biological data are increasingly clear that some form of artificial gravity may be necessary for missions lasting years rather than months.
Planning for Mars With Incomplete Data
Despite the progress, major uncertainties remain. Rodent physiology is not identical to human physiology, and the 27–28 day exposure in the ISS experiments is far shorter than the 18 to 30 months a crewed Mars mission might require, including transit and surface time. It is possible that humans could adapt differently, or that combinations of partial gravity, exercise, and pharmacological support could prove more effective than mouse studies suggest. It is equally possible that long-term effects could be worse than projected, especially for bones and the cardiovascular system.
Bridging that gap will require more targeted research. Future ISS missions could extend partial-gravity exposures to several months, include larger animal cohorts, and integrate more human-relevant outcome measures such as bone density imaging and cardiovascular monitoring. Ground-based analogs, such as centrifuge beds and partial-weight-bearing rigs, can help refine hypotheses but cannot fully replicate the complex environment of space. Ultimately, planners may need to accept a degree of uncertainty and design Mars missions with built-in flexibility to adjust countermeasures as new data emerge.
Implications for Astronaut Health Policy
The emerging picture has policy as well as engineering implications. If partial gravity is formally recognized as insufficient to protect health, agencies may need to revise medical standards for long-duration missions, set stricter limits on cumulative exposure, or require specific artificial-gravity provisions in mission architectures. Such decisions will hinge on continued evaluation of experimental results by experts in aerospace medicine, physiology, and human factors.
For researchers and mission planners seeking more detailed technical information, NASA encourages direct engagement through its scientific information channels. The agency’s spaceflight health reports and related documentation can be accessed via its technical information services, and questions or data requests can be directed through official contact points. As the mouse data underscore, the stakes are high: without robust strategies to counter muscle and neuromotor decline, the first humans to walk on Mars could find themselves physically diminished just when they are needed at their strongest.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
